Company: WHWK
Filing Date: 2025-01-31
Form Type: DEFM14A
Source: 0001193125-25-018470
Chunk: 139

Company: Whitehawk Therapeutics, Inc.
Filing Date: 2025-01-31
Form: DEFM14A
Chunk 139
---
 agreed to pay Kaken a one-time termination fee of $3.5 million. Specifically, this termination fee will be payable by Aadi to Kaken if any one of the following occur, under which circumstances the termination fee will be the sole and exclusive remedy of Kaken against Aadi for the termination of the Divestiture Agreement or the failure to complete the Divestiture:

| • |     | (1) the Divestiture Agreement is terminated because the completion of the Divestiture has not occurred by the                                                                                                                               
 Termination Date, or because of Aadi’s failure to obtain the required approval of Aadi stockholders; (2) at the time of such termination, certain of the closing conditions set forth in the Divestiture Agreement have not been satisfied; 
 (3) prior to the termination of the Divestiture Agreement, an acquisition proposal to engage in an Acquisition Transaction (as defined in the Divestiture Agreement) (except that all references to “15%” in the definition of Acquisition  
 Transaction in the Divestiture Agreement will be deemed to be references to “50%”) is received from any person other than Kaken or any of its affiliates has been publicly announced or publicly disclosed and not withdrawn or otherwise   
 abandoned at within a certain period prior to the termination of the Divestiture Agreement; and (4) within one year of the termination of the Divestiture Agreement, either an Acquisition Transaction (except that all references to       
 “15%” in the definition of Acquisition Transaction in the Divestiture Agreement will be deemed to be references to “50%”) is consummated, or Aadi or Aadi Sub enter into a definitive agreement providing for the consummation of           
 such a transaction and it is subsequently completed;                                                                                                                                                                                        |

- 93 -

| • |     | the Divestiture Agreement is terminated by Kaken after Aadi’s board of directors changes its recommendation 
 with respect to the Divestiture;                                                                            |

| • |     | the Divestiture Agreement is terminated by Aadi, prior to the approval of the Divestiture Agreement and the                                                                                                                              
 Divestiture by the requisite affirmative vote of Aadi stockholders, if (1) Aadi has received a Superior Proposal; (2) Aadi’s board of directors has authorized Aadi to enter into an Alternative Acquisition Agreement to consummate the 
 acquisition transaction contemplated by such Superior Proposal; and (3) Aadi has complied in all material respects with its obligations under the Superior Proposal provisions